Preclinical Imaging Clinical Life Sciences

Increasing the pace of innovation

Preclinical Imaging

How Bruker’s preclinical imaging solutions help to discover new drugs and significantly shorten time-to-market by delivering earlier and more highly predictive data

Since it takes huge investments and many years to bring new drugs to market, it is crucial to improve the throughput of testing – especially in early phases. Preclinical imaging can dramatically increase the efficiency and pace of drug discovery and development. It helps to create more realistic models of human disease at any stage as well as transgenic mouse models.

Bruker offers advanced preclinical imaging solutions for a broad spectrum of application fields, such as cancer research, functional and anatomical neuroimaging, orthopedics, cardiac imaging and stroke models. Our range of techniques includes resonance imaging (MRI), PET/MRI imaging, micro-CT and magnetic particle (MPI) as well as MALDI imaging.